Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
low lactose milk + galactooligosaccharides
- Development stage
- Unknown
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
This novel milk formulation is produced through the enzymatic conversion of lactose into galacto-oligosaccharides (GOS) using a one-step in situ trans-galactosylation process. The resulting product is characterized by a low lactose content (approximately 1.7g per serving) and a high concentration of prebiotic GOS (approximately 9g per serving). The primary mechanism of action involves the modulation of the intestinal microbiota, specifically promoting the proliferation of beneficial *Bifidobacterium* species. Clinical research, including a 2025 double-blind controlled trial, indicates that regular consumption can significantly alter gut microbial abundance and related metabolic pathways, potentially offering benefits for gut health and the management of lactose intolerance symptoms.
- Other names
- GOS-enriched low-lactose milkin situ GOS milk
Beyond the preview
Go deeper on low lactose milk + galactooligosaccharides.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on low lactose milk + galactooligosaccharides.